文献速递膀胱癌与上尿路尿路上皮癌

低能量冲击波增强膀胱内表柔比星递送的大鼠膀胱癌模型研究

Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer.
PubMed 文献 · BJU Int · 2020-08-07

本研究在大鼠膀胱癌模型中评估低能量冲击波(LESW)增强膀胱内表柔比星(EPI)递送的效果。100只雌性Fischer大鼠随机分为五组,每周治疗一次共6周。结果显示EPI联合LESW组死亡率、体重下降和膀胱/体重比显著降低,组织病理学改善,p53、miR-210、HIF-1α、TNF-α和IL-6表达降低,LESW使EPI尿路上皮浓度增加5.7倍(P < 0.001),且无实验室毒性。

要点

  • LESW使膀胱尿路上皮EPI浓度提高5.7倍(P < 0.001)。
  • 联合治疗组死亡率、体重下降和膀胱/体重比显著降低。
  • 联合治疗改善组织病理学并降低p53、miR-210、HIF-1α、TNF-α、IL-6表达。

核心结论

  • 膀胱内EPI联合LESW可减少膀胱癌侵袭和发育不良形成,因LESW增加EPI尿路上皮通透性并增强其向肿瘤组织递送,且不增加毒性。

研究设计与样本

  • 研究纳入100只雌性Fischer大鼠,随机分为五组:对照组、膀胱癌组、LESW组、EPI组和EPI联合LESW组。
  • 膀胱癌由N-丁基-N-(4-羟丁基)亚硝胺诱导,EPI剂量为0.6 mg/0.3 mL稀释于0.3 mL生理盐水,或生理盐水0.6 mL,膀胱内保留1小时,联合或不联合LESW(300脉冲,0.12 mJ/mm2),每周重复共6周。

主要发现

  • EPI联合LESW组死亡率、体重下降和膀胱/体重比显著低于其他组。
  • EPI联合LESW组在肉眼可见膀胱病变、黏膜厚度、发育不良形成和肿瘤侵袭方面组织病理学结果显著更好。
  • EPI联合LESW组p53、miR-210、HIF-1α、TNF-α和IL-6表达水平显著降低。
  • LESW使EPI尿路上皮浓度增加5.7倍(P < 0.001)。
  • EPI联合LESW组EPI诱导的心肌病指标(充血、玻璃样变和微泡性脂肪变性)改善,P值分别为0.068、0.003和0.046。

关键数值与推荐

  • LESW参数:300脉冲,0.12 mJ/mm2。
  • EPI剂量:0.6 mg/0.3 mL稀释于0.3 mL生理盐水。
  • 治疗频率:每周一次,共6周。

临床怎么用

  • LESW可能作为增强膀胱内化疗药物递送的辅助手段,但需进一步临床验证。
  • 联合治疗可能减少膀胱癌侵袭和发育不良,且不增加实验室毒性。

局限性

  • 本研究为大鼠模型,结果不能直接外推至人类。
  • 样本量为100只大鼠,结论需更大规模研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To study the efficacy of low-energy shock wave therapy (LESW) on enhancing intravesical epirubicin (EPI) delivery in a rat model of bladder cancer (BCa). MATERIALS AND METHODS: A total of 100 female Fischer rats were randomly allocated into five groups: control; BCa; LESW; EPI; and EPI plus LESW. After BCa induction by N-butyl-N-(4-hydroxybutyl)nitrosamine, EPI (0.6 mg/0.3 mL of EPI diluted in 0.3 mL saline) or saline (0.6 mL) was administered and retained in the bladders for 1 h with or without LESW treatment (300 pulses at 0.12 mJ/mm2 ). This was repeated weekly for 6 weeks. Survival was then calculated, rats were weighed and their bladders were harvested for bladder/body ratio estimation, histopathological examination, p53 immunostaining, miR-210, hypoxia-inducible factor (HIF)-1α, tumour necrosis factor (TNF)-α and interleukin (IL)-6 relative gene expression and fluorescence spectrophotometric drug quantification. Heart and blood samples were also collected for assessment of the safety profile and toxicity. RESULTS: The EPI plus LESW group had significantly lower mortality rates, loss of body weight and bladder/body ratio. Histopathological results in terms of grossly visible bladder lesions, mucosal thickness, dysplasia formation and tumour invasion were significantly better in the combined treatment group. The EPI plus LESW group also had statistically significant lower expression levels of p53 , miR-210, HIF-1α, TNF-α and IL-6. LESW increased urothelial concentration of EPI by 5.7-fold (P < 0.001). No laboratory variable exceeded the reference ranges in any of the groups. There was an improvement of the indicators of EPI-induced cardiomyopathy in terms of congestion, hyalinization and microvesicular steatosis of cardiomyocytes (P = 0.068, 0.003 and 0.046, respectively) in the EPI plus LESW group. CONCLUSIONS: The combined use of intravesical EPI and LESW results in less BCa invasion and less dysplasia formation, as LESW increases urothelial permeability of EPI and enhances its delivery into tumour tissues, without subsequent toxicity.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Elkashef A, Barakat N, Khater SM, et al. Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer. BJU Int. 2020. PMID: 32654305. doi:10.1111/bju.15173

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。